Curaleaf Holdings, Inc.: Form 40-F for the period ended Dec 31, 2023
Filed with the SEC on Mar 7, 2024 and accepted by EDGAR at Mar 6, 2024, 21:44 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-01-01 to 2023-12-31 | $1.35bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2023-01-01 to 2023-12-31 | $732.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2023-01-01 to 2023-12-31 | $614.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2023-01-01 to 2023-12-31 | $414.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2023-01-01 to 2023-12-31 | $42.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2023-01-01 to 2023-12-31 | $114.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2023-01-01 to 2023-12-31 | −$281.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | −$0.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | −$0.39 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 724,124,894 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | $75.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-01-01 to 2023-12-31 | $65.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2023-12-31 | $418.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $3.10bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $494.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $1.93bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-12-31 | $548.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-12-31 | $39.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-12-31 | $1.05bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001756770-24-000016. Last ingested by Listed: Nov 10, 2026, 22:51 ET. Listed shows no prices and gives no investment advice.